Comparison of Exercise Testing and CMR Measured Myocardial Perfusion Reserve for Predicting Outcome in Asymptomatic Aortic Stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study

Overview

Journal Eur Heart J

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2017 Feb 17

PMID 28204448

Citations 33

Authors

Anvesha Singh

John P Greenwood

Colin Berry

Dana K Dawson

Kai Hogrefe

Damian J Kelly

Vijay Dhakshinamurthy

Chim C Lang

Jeffrey P Khoo

David Sprigings

Richard P Steeds

Michael Jerosch-Herold

Stefan Neubauer

Bernard Prendergast

Bryan Williams

Ruiqi Zhang

Ian Hudson

Iain B Squire

Ian Ford

Nilesh J Samani

Gerry P McCann

Affiliations

Soon will be listed here.

Abstract

Aims: To assess cardiovascular magnetic resonance (CMR) measured myocardial perfusion reserve (MPR) and exercise testing in asymptomatic patients with moderate-severe AS.

Methods And Results: Multi-centre, prospective, observational study, with blinded analysis of CMR data. Patients underwent adenosine stress CMR, symptom-limited exercise testing (ETT) and echocardiography and were followed up for 12-30 months. The primary outcome was a composite of: typical AS symptoms necessitating referral for AVR, cardiovascular death and major adverse cardiovascular events. 174 patients were recruited: mean age 66.2 ± 13.34 years, 76% male, peak velocity 3.86 ± 0.56 m/s and aortic valve area index 0.57 ± 0.14 cm2/m2. A primary outcome occurred in 47 (27%) patients over a median follow-up of 374 (IQR 351-498) days. The mean MPR in those with and without a primary outcome was 2.06 ± 0.65 and 2.34 ± 0.70 (P = 0.022), while the incidence of a symptom-limited ETT was 45.7% and 27.0% (P = 0.020), respectively. MPR showed moderate association with outcome area under curve (AUC) = 0.61 (0.52-0.71, P = 0.020), as did exercise testing (AUC = 0.59 (0.51-0.68, P = 0.027), with no significant difference between the two.

Conclusions: MPR was associated with symptom-onset in initially asymptomatic patients with AS, but with moderate accuracy and was not superior to symptom-limited exercise testing. ClinicalTrials.gov (NCT01658345).

Citing Articles

The association between triglyceride to high-density-lipoprotein cholesterol ratio and calcific aortic valve disease: a retrospective study.

Chen Z, Liu L, Jiao X, Zhang Y, Wang F, Chen Y BMC Cardiovasc Disord. 2024; 24(1):708.

PMID: 39702057 PMC: 11656935. DOI: 10.1186/s12872-024-04372-2.

Unravelling the Fate of Coronary Artery Disease in Patients Undergoing Valve Replacement for Severe Aortic Valve Stenosis.

Minten L, Bennett J, McCutcheon K, Dubois C Rev Cardiovasc Med. 2024; 24(3):68.

PMID: 39077476 PMC: 11263999. DOI: 10.31083/j.rcm2403068.

Type 2 Diabetes, Circulating Metabolites, and Calcific Aortic Valve Stenosis: A Mendelian Randomization Study.

Shen R, Pan C, Yi G, Li Z, Dong C, Yu J Metabolites. 2024; 14(7).

PMID: 39057708 PMC: 11278608. DOI: 10.3390/metabo14070385.

Prognostic Value of Stress Perfusion Cardiac MRI in Cardiovascular Disease: A Systematic Review and Meta-Analysis of the Effects of the Scanner, Stress Agent, and Analysis Technique.

Fu Q, Alabed S, Hoole S, Abraham G, Weir-McCall J Radiol Cardiothorac Imaging. 2024; 6(3):e230382.

PMID: 38814186 PMC: 11211944. DOI: 10.1148/ryct.230382.

Myocardial Blood Flow Reserve, Microvascular Coronary Health, and Myocardial Remodeling in Patients With Aortic Stenosis.

Alahdab F, Ahmed A, Nayfeh M, Han Y, Abdelkarim O, Alfawara M J Am Heart Assoc. 2024; 13(11):e033447.

PMID: 38780160 PMC: 11255635. DOI: 10.1161/JAHA.123.033447.

References

Alborino D, Hoffmann J, Fournet P, Bloch A . Value of exercise testing to evaluate the indication for surgery in asymptomatic patients with valvular aortic stenosis. J Heart Valve Dis. 2002; 11(2):204-9. View

Dweck M, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G . Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011; 58(12):1271-9. DOI: 10.1016/j.jacc.2011.03.064. View

Flett A, Sado D, Quarta G, Mirabel M, Pellerin D, Herrey A . Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging. 2012; 13(10):819-26. DOI: 10.1093/ehjci/jes102. View

McCann G, Steadman C, Ray S, Newby D . Managing the asymptomatic patient with severe aortic stenosis: randomised controlled trials of early surgery are overdue. Heart. 2011; 97(14):1119-21. DOI: 10.1136/hrt.2011.223800. View

Amato M, Moffa P, Werner K, Ramires J . Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001; 86(4):381-6. PMC: 1729928. DOI: 10.1136/heart.86.4.381. View

Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard L . Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation. 2005; 112(9 Suppl):I377-82. DOI: 10.1161/CIRCULATIONAHA.104.523274. View

Sado D, Flett A, Banypersad S, White S, Maestrini V, Quarta G . Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012; 98(19):1436-41. DOI: 10.1136/heartjnl-2012-302346. View

Lancellotti P, Donal E, Magne J, Moonen M, OConnor K, Daubert J . Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart. 2010; 96(17):1364-71. DOI: 10.1136/hrt.2009.190942. View

Banovic M, Bosiljka V, Voin B, Milan P, Ivana N, Dejana P . Prognostic value of coronary flow reserve in asymptomatic moderate or severe aortic stenosis with preserved ejection fraction and nonobstructed coronary arteries. Echocardiography. 2013; 31(4):428-33. DOI: 10.1111/echo.12404. View

10.

Villar A, Llano M, Cobo M, Exposito V, Merino R, Martin-Duran R . Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J Mol Cell Cardiol. 2009; 46(4):526-35. DOI: 10.1016/j.yjmcc.2008.12.024. View

11.

Monin J, Lancellotti P, Monchi M, Lim P, Weiss E, Pierard L . Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation. 2009; 120(1):69-75. DOI: 10.1161/CIRCULATIONAHA.108.808857. View

12.

Singh A, Ford I, Greenwood J, Khan J, Uddin A, Berry C . Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations. BMJ Open. 2013; 3(12):e004348. PMC: 3884636. DOI: 10.1136/bmjopen-2013-004348. View

13.

Singh A, Horsfield M, Bekele S, Khan J, Greiser A, McCann G . Myocardial T1 and extracellular volume fraction measurement in asymptomatic patients with aortic stenosis: reproducibility and comparison with age-matched controls. Eur Heart J Cardiovasc Imaging. 2015; 16(7):763-70. DOI: 10.1093/ehjci/jev007. View

14.

Steadman C, Jerosch-Herold M, Grundy B, Rafelt S, Ng L, Squire I . Determinants and functional significance of myocardial perfusion reserve in severe aortic stenosis. JACC Cardiovasc Imaging. 2012; 5(2):182-9. DOI: 10.1016/j.jcmg.2011.09.022. View

15.

Nemes A, Balazs E, Csanady M, Forster T . Long-term prognostic role of coronary flow velocity reserve in patients with aortic valve stenosis - insights from the SZEGED Study. Clin Physiol Funct Imaging. 2009; 29(6):447-52. DOI: 10.1111/j.1475-097X.2009.00893.x. View

16.

Flett A, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C . Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011; 4(2):150-6. DOI: 10.1016/j.jcmg.2010.11.015. View

17.

Barone-Rochette G, Pierard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F . Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014; 64(2):144-54. DOI: 10.1016/j.jacc.2014.02.612. View

18.

Vahanian A, Alfieri O, Andreotti F, Antunes M, Baron-Esquivias G, Baumgartner H . Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19):2451-96. DOI: 10.1093/eurheartj/ehs109. View

19.

Das P, Rimington H, Chambers J . Exercise testing to stratify risk in aortic stenosis. Eur Heart J. 2005; 26(13):1309-13. DOI: 10.1093/eurheartj/ehi250. View

20.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Guyton R . 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(23):2440-92. DOI: 10.1161/CIR.0000000000000029. View